Skip to content

Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms

Efficacy and Safety of StENt-assisted Treatment for CErebral Aneurysms

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01702584
Enrollment
500
Registered
2012-10-08
Start date
2012-09-30
Completion date
2021-03-31
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stent Embolisation

Keywords

stent, intracranial aneurysm, embolization, adverse event

Brief summary

Prospective registry study to evaluate safety and efficacy of stent assisted embolization of intracranial aneurysm.

Detailed description

To evaluate stent assisted embolization of intracranial aneurysm, record information about treatment and any event (death, stroke, hemorrhagic event) prospectively.

Interventions

PROCEDUREstent assisted embolization

stent assisted embolization and anti-thrombotic management

Sponsors

Kobe City General Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* stent assisted embolization of intracranial aneurysm * 20 or more year old

Exclusion criteria

* not determined

Design outcomes

Primary

MeasureTime frameDescription
any death, stroke and major hemorrhagic event2 years after treatmentany death, stroke and major hemorrhagic event within 2 years after treatment

Secondary

MeasureTime frameDescription
any adverse event2 years1. death, stroke, hemorrhagic event within 30days or between 31days to 2years after treatment 2. any change of anti-thrombotic therapy within 2years after treatment 3. recanalization or re-treatment within 2years after treatment 4. stent stenosis or occlusion within 2years after treatment 5. any adverse event within 2years after treatment

Countries

Japan

Contacts

Primary ContactNobuyuki Sakai, MD, DMSc
n.sakai@siren.ocn.ne.jp81783024321

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026